Juan Delgado-Moreira
Known title: Co-Chief Executive OfficerCIK: 0001698040
Juan Delgado-Moreira's purchase track record
How the stock did after each of Juan Delgado-Moreira's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
4
of 4 since August 31, 2022
Stock higher 6 months later
25%
3 months: 50%
Median 6-month return
-7.0%
3 months: -7.1%
Beat the S&P 500
25%
median -11.2% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 2/20/2026 | HLNE | $989K | -15.2% | -0.3% | +11.1% |
| 11/7/2025 | HLNE | $1.04M | +0.9% | -31.4% | +10.0% |
| 11/11/2024 | HLNE | $106K | -17.2% | -13.7% | -2.6% |
| 8/31/2022 | HLNE | $1.04M | +6.8% | +12.8% | -0.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| HLNE | ▼ Sell | Gift | 50,000 | $0 | 9/10/2026 | View on chart |
| HLNE | ▼ Sell | Gift | 50,000 | $0 | 9/10/2026 | View on chart |
| HLNE | ▲ Buy | Grant | 38,087 | $0 | 5/29/2026 | View on chart |
| HLNE | ▲ Buy | Open Market | 6,520 | $698K | 2/20/2026 | View on chart |
| HLNE | ▲ Buy | Open Market | 2,705 | $291K | 2/20/2026 | View on chart |
| HLNE | ▼ Sell | Gift | 14,375 | $0 | 2/6/2026 | View on chart |
| HLNE | ▼ Sell | Gift | 14,375 | $0 | 2/6/2026 | View on chart |
| HLNE | ▲ Buy | Open Market | 4,008 | $520K | 11/7/2025 | View on chart |
| HLNE | ▲ Buy | Open Market | 3,992 | $522K | 11/7/2025 | View on chart |
| HLNE | ▼ Sell | Gift | 7,600 | $0 | 8/28/2025 | View on chart |
| HLNE | ▼ Sell | Gift | 7,600 | $0 | 8/28/2025 | View on chart |
| HLNE | ▲ Buy | Grant | 34,031 | $0 | 3/14/2025 | View on chart |
| HLNE | ▲ Buy | Open Market | 525 | $106K | 11/11/2024 | View on chart |
| HLNE | ▲ Buy | Grant | 5,364 | $0 | 3/14/2024 | View on chart |
| HLNE | ▲ Buy | Grant | 9,285 | $0 | 3/14/2023 | View on chart |
| HLNE | ▲ Buy | Open Market | 2,649 | $184K | 9/1/2022 | View on chart |
| HLNE | ▲ Buy | Open Market | 12,351 | $857K | 8/31/2022 | View on chart |
| HLNE | ▲ Buy | Grant | 7,248 | $0 | 4/8/2022 | View on chart |
| HLNE | ▼ Sell | Open Market | 61,864 | $5.2M | 9/10/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
Wells Fargo initiates coverage on Hamilton Lane with Overweight rating
Wells Fargo has started covering Hamilton Lane, assigning an Overweight rating and a price target of $103. This new analyst view comes as the company prepares to report second-quarter results in November. Additionally, attention is turning to the planned 2027 retirement of a key executive, which may influence long-term expectations for the firm.
Wells Fargo initiates coverage on Hamilton Lane with Overweight rating. Wells Fargo has started covering Hamilton Lane, assigning an Overweight rating and a price target of $103. This new analyst view comes as the company prepares to report second-quarter results in November. Additionally, attention is turning to the planned 2027 retirement of a key executive, which may influence long-term expectations for the firm.